Surgical management of pancreatic cancer.

Steven A. Ahrendt, Henry A. Pitt

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)725-734
Number of pages10
JournalOncology
Volume16
Issue number6
StatePublished - Jun 2002
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Pancreaticoduodenectomy
Cause of Death
Length of Stay
Survival Rate
Survival
Mortality
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Ahrendt, S. A., & Pitt, H. A. (2002). Surgical management of pancreatic cancer. Oncology, 16(6), 725-734.

Surgical management of pancreatic cancer. / Ahrendt, Steven A.; Pitt, Henry A.

In: Oncology, Vol. 16, No. 6, 06.2002, p. 725-734.

Research output: Contribution to journalArticle

Ahrendt, SA & Pitt, HA 2002, 'Surgical management of pancreatic cancer.', Oncology, vol. 16, no. 6, pp. 725-734.
Ahrendt SA, Pitt HA. Surgical management of pancreatic cancer. Oncology. 2002 Jun;16(6):725-734.
Ahrendt, Steven A. ; Pitt, Henry A. / Surgical management of pancreatic cancer. In: Oncology. 2002 ; Vol. 16, No. 6. pp. 725-734.
@article{80e4515e26064bf4a25e24fecda6f2d6,
title = "Surgical management of pancreatic cancer.",
abstract = "Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3{\%}. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20{\%} in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.",
author = "Ahrendt, {Steven A.} and Pitt, {Henry A.}",
year = "2002",
month = "6",
language = "English (US)",
volume = "16",
pages = "725--734",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "6",

}

TY - JOUR

T1 - Surgical management of pancreatic cancer.

AU - Ahrendt, Steven A.

AU - Pitt, Henry A.

PY - 2002/6

Y1 - 2002/6

N2 - Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.

AB - Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0036599065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036599065&partnerID=8YFLogxK

M3 - Article

C2 - 12088296

AN - SCOPUS:0036599065

VL - 16

SP - 725

EP - 734

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 6

ER -